Rocket Pharmaceuticals logo
Rocket Pharmaceuticals RCKT
$ 16.59 -1.37%

Quarterly report 2024-Q2
added 08-06-2024

report update icon

Rocket Pharmaceuticals EV/EBITDA Ratio 2011-2024 | RCKT

Annual EV/EBITDA Ratio Rocket Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-4.91 -20.9 -12.4 -6.75 -3.31 -1.45 -3.11 - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.45 -20.9 -7.55